⌘K

Home/Filings/4/0000899243-21-011693

4//SEC Filing

CAIN CHRISTOPHER W. 4

Accession 0000899243-21-011693

CIK 0001622229other

View on SEC.gov Company Profile

Filed

Mar 14, 8:00 PM ET

Accepted

Mar 15, 7:00 PM ET

Size

9.5 KB

Accession

0000899243-21-011693

Insider Transaction Report

Form 4

Period: 2021-03-11

Cogent Biosciences, Inc.COGT

CAIN CHRISTOPHER W.

Director

Transactions

Award
Stock Option (Right to Buy)
2021-03-11+60,000→ 60,000 total
Exercise: $8.45Exp: 2031-03-11→ Common Stock (60,000 underlying)

Footnotes (1)

[F1]This stock option shall vest in equal monthly installments over a three year period.

Documents

2 files

Issuer

Cogent Biosciences, Inc.

CIK 0001622229

Entity typeother

Related Parties

1

filerCIK 0001817733

Filing Metadata

Form type: 4
Filed: Mar 14, 8:00 PM ET
Accepted: Mar 15, 7:00 PM ET
Size: 9.5 KB

View on SEC.gov